UPDATE: Demant Group IT Infrastructure Falls Victim to “Cyber Crime” Incident
According to a statement, the Demant Group “experienced a critical incident on our internal IT infrastructure on 3 September 2019”. The critical incident is being labeled as cyber-crime. The impact has affected various systems globally, with reports in both the US and Europe of communication systems down at times throughout the week. The company provided…
Read More
Chronic Conductive Hearing Loss May Result in Poorer Speech Discrimination Ability
BOSTON, MASSACHUSETTS — According to a newly published study led by Harvard Medical School scientists at Massachusetts Eye and Ear, chronic conductive hearing loss may have lasting negative effects on speech recognition. The research, published Sept. 6 in the journal Ear and Hearing, suggests that not properly treating infections or other conditions that chronically affect the middle ear…
Read More
Akouos Announces New Executive Leadership Team Appointments
BOSTON, MASSACHUSETTS — Akouos, a precision genetic medicine company developing gene therapies to restore and preserve hearing, announced two key leadership appointments this week. Gregory Robinson, Ph.D., has joined the company as chief scientific officer, and co-founder Michael McKenna, M.D., expands his role to full-time chief medical officer. Using Gene Therapy to Restore and…
Read More
WS Audiology A/S Announces Management Changes; Names New Group CEO
LYNGE, DENMARK AND SINGAPORE — Following a period of careful consideration, Jørgen Jensen has decided to step down as President and CEO of WS Audiology A/S to pursue a career as a board member. He led the company throughout the integration process following the successful merger of Widex A/S and Sivantos Pte. Ltd. after serving…
Read More
Strekin AG Secures Financing to Complete Development of STR001 in Sudden Sensorineural Hearing Loss
BASEL, SWITZERLAND — Strekin AG, a clinical stage biopharmaceutical company, announced today that it has successfully closed a Series A financing round totaling CHF 2.82 Million (~$2.86M USD) from private investors. According to the announcement, the funds will enable Strekin to conclude its ongoing Phase 3 clinical trial of STR001 in Sudden Sensorineural Hearing Loss,…
Read More
Auris Medical Forms Scientific Advisory Board for Tinnitus Programs
HAMILTON, BERMUDA — Biopharmaceutical company Auris Medical Holdings has announced the formation of a Scientific Advisory Board (SAB) for its tinnitus research and development programs. “We are delighted to have several world-renowned tinnitus experts join Auris Medical as advisors as we are preparing to advance our various tinnitus projects through further clinical and pre-clinical development.…
Read More
Interim Report Q2 2019: GN Group Posts Strong Performance; Upgrades Guidance for GN Audio
BALLERUP, DENMARK — The GN Group posted another strong quarter, delivering 16% organic revenue growth in Q2 2019 compared with Q2 2018, according to the company’s Interim Report Q2 2019. GN Interim Report Q2 2019 Highlights GN delivered 16% organic revenue growth in Q2 2019. Revenue growth was 19% including around 3% impact…
Read More
Father and Son Sentenced to Prison in $27 Million Dollar Hearing Aid Insurance Fraud Scheme
A father and son duo that submitted more than $27 million in fraudulent hearing aid claims to insurer Blue Cross and Blue Shield of Texas was sentenced to eight and seven years in federal prison, respectively, announced U.S. Attorney for the Northern District of Texas Erin Nealy Cox. Terry Lynn Anderson, 69, and Rocky Freeland…
Read More
Auris Medical Announces Randomization of First Patient into Phase 2 Trial of Vertigo Drug
Biopharmaceutical company Auris Medical Holdings announced that the first patient has been randomized in its “TRAVERS” Phase 2 trial of AM-125, the company’s investigational drug for the treatment of acute vertigo. The TRAVERS trial will enroll a total of 138 patients who suffer from acute vertigo following surgical removal of a vestibular schwannoma, a tumor…
Read More
Ida Institute to Hold Inaugural Person-Centered Hearing Network Meeting
NAERUM, DENMARK — The Ida Institute will convene the inaugural meeting of the Person-Centered Hearing Network (PCHN) on August 27-28 in Skodsborg, Denmark. The meeting will bring together representatives of leading patient organizations, educational institutions, professional organizations, and care providers from around the world to exchange knowledge and ideas and discuss concrete collaboration opportunities. “The purpose…
Read More